Detalles de la búsqueda
1.
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.
BMC Cancer
; 16: 25, 2016 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26775260
2.
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms.
Mol Cancer
; 12: 19, 2013 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23497317
3.
Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia.
Mol Cancer
; 12: 46, 2013 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23705826
4.
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
EBioMedicine
; 42: 340-351, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952616
5.
Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia.
Oncotarget
; 8(47): 82897-82909, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137311
Resultados
1 -
5
de 5
1
Próxima >
>>